Debt-to-equity of CORCEPT THERAPEUTICS INC from 30 Sep 2019 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CORCEPT THERAPEUTICS INC quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 31 Dec 2025.
  • CORCEPT THERAPEUTICS INC Debt-to-equity for the quarter ending 31 Dec 2025 was 27%, a 26% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

CORCEPT THERAPEUTICS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 27% +5.7% +26% 31 Dec 2025
Q3 2025 26% +4.7% +22% 30 Sep 2025
Q2 2025 24% +1.7% +7.5% 30 Jun 2025
Q1 2025 23% -1% -4.3% 31 Mar 2025
Q4 2024 22% -1.2% -5.3% 31 Dec 2024
Q3 2024 21% +0.09% +0.43% 30 Sep 2024
Q2 2024 22% +5.1% +30% 30 Jun 2024
Q1 2024 24% +9.1% +62% 31 Mar 2024
Q4 2023 23% +8.8% +63% 31 Dec 2023
Q3 2023 21% +8.1% +62% 30 Sep 2023
Q2 2023 17% +5.5% +47% 30 Jun 2023
Q1 2023 15% +3.8% +35% 31 Mar 2023
Q4 2022 14% +4.8% +51% 31 Dec 2022
Q3 2022 13% +4.4% +52% 30 Sep 2022
Q2 2022 12% +2.9% +33% 30 Jun 2022
Q1 2022 11% +1.8% +19% 31 Mar 2022
Q4 2021 9.3% +0.04% +0.44% 31 Dec 2021
Q3 2021 8.6% -0.98% -10% 30 Sep 2021
Q2 2021 8.8% -1% -10% 30 Jun 2021
Q1 2021 9% -0.91% -9.1% 31 Mar 2021
Q4 2020 9.2% -1.6% -14% 31 Dec 2020
Q3 2020 9.6% -1.6% -14% 30 Sep 2020
Q2 2020 9.8% 30 Jun 2020
Q1 2020 9.9% 31 Mar 2020
Q4 2019 11% 31 Dec 2019
Q3 2019 11% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.